Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of "A-β plus " ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilection

被引:43
作者
Nalini, Ramaswami [3 ]
Ozer, Kerem [3 ]
Maldonado, Mario [2 ]
Patel, Sanjeet G.
Hampe, Christiane S. [4 ]
Guthikonda, Anu [3 ]
Villanueva, Jesus [3 ]
Smith, E. O'Brian [5 ]
Gaur, Lakshmi K. [6 ]
Balasubramanyam, Ashok [1 ,3 ]
机构
[1] Baylor Coll Med, Div Diabet Endocrinol & Metab, Translat Metab Unit, Houston, TX 77030 USA
[2] Novartis Inc, Basel, Switzerland
[3] Ben Taub Gen Hosp, Endocrine Serv, Houston, TX 77030 USA
[4] Univ Washington, Dept Med, Seattle, WA 98195 USA
[5] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[6] Univ Washington, Puget Sound Blood Ctr, Seattle, WA 98104 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2010年 / 59卷 / 10期
关键词
MELLITUS; TYPE-2; CLASSIFICATION; PATHOGENESIS; CONSENSUS; NIDDM;
D O I
10.1016/j.metabol.2010.01.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ketosis-prone diabetes (KPD) is heterogeneous. Longitudinal follow-up revealed that patients with "A-beta+" KPD (absent autoantibodies and preserved beta-cell function) segregated into 2 subgroups with distinct evolution of beta-cell function and glycemic control. Generalized linear analysis demonstrated that the variable that most significantly differentiated them was presence of a clinically evident precipitating event for the index diabetic ketoacidosis (DKA). Hence, we performed a comprehensive analysis of A-beta+ KPD patients presenting with "provoked" compared with "unprovoked" DKA. Clinical, biochemical, and beta-cell functional characteristics were compared between provoked and unprovoked A-beta+ KPD patients followed prospectively for 1 to 8 years. Human leukocyte antigen class II allele frequencies were compared between these 2 groups and population controls. Unprovoked A-beta+ KPD patients (n = 83) had greater body mass index, male preponderance, higher frequency of women with oligo-/anovulation, more frequent African American ethnicity, and less frequent family history of diabetes than provoked A-beta+ KPD patients (n = 64). The provoked group had higher frequencies of the human leukocyte antigen class 11 type I diabetes mellitus susceptibility alleles DQB1*0302 (than the unprovoked group or population controls) and DRB1*04 (than the unprovoked group), whereas the unprovoked group had a higher frequency of the protective allele DQB1*0602. beta-Cell secretory reserve and glycemic control improved progressively in the unprovoked group but declined in the provoked group. The differences persisted in comparisons restricted to patients with new-onset diabetes. "Unprovoked" A-beta+ KPD is a distinct syndrome characterized by reversible beta-cell dysfunction with male predominance and increased frequency of DQB1*0602, whereas "provoked" A-beta+ KPD is characterized by progressive loss of beta-cell reserve and increased frequency of DQB1*0302 and DRB1*04. Unprovoked DKA predicts long-term beta-cell functional reserve, insulin independence, and glycemic control in KPD. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:1448 / 1455
页数:8
相关论文
共 22 条
  • [1] Aizawa T, 1997, DIABETIC MED, V14, P989
  • [2] Syndromes of ketosis-prone diabetes mellitus
    Balasubramanyam, Ashok
    Nalini, Ramaswami
    Hampe, Christiane S.
    Maldonado, Mario
    [J]. ENDOCRINE REVIEWS, 2008, 29 (03) : 292 - 302
  • [3] Accuracy and predictive value of classification schemes for ketosis-prone diabetes
    Balasubramanyam, Ashok
    Garza, Gilberto
    Rodriguez, Lucille
    Hampe, Christiane S.
    Gaur, Lakshmi
    Lernmark, Ake
    Maldonado, Mario R.
    [J]. DIABETES CARE, 2006, 29 (12) : 2575 - 2579
  • [4] GAD ANTIBODY NEGATIVE NIDDM IN ADULT BLACK SUBJECTS WITH DIABETIC-KETOACIDOSIS AND INCREASED FREQUENCY OF HUMAN-LEUKOCYTE ANTIGEN DR3 AND DR4 - FLATBUSH DIABETES
    BANERJI, MA
    CHAIKEN, RL
    HUEY, H
    TUOMI, T
    NORIN, AJ
    MACKAY, IR
    ROWLEY, MJ
    ZIMMET, PZ
    LEBOVITZ, HE
    [J]. DIABETES, 1994, 43 (06) : 741 - 745
  • [5] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
    Fauser, BCJM
    Chang, J
    Azziz, R
    Legro, R
    Dewailly, D
    Franks, S
    Tarlatzis, BC
    Fauser, B
    Balen, A
    Bouchard, P
    Dahlgren, E
    Devoto, L
    Diamanti, E
    Dunaif, A
    Filicori, M
    Homburg, R
    Ibanez, L
    Laven, J
    Magoffin, D
    Nestler, J
    Norman, RJ
    Pasquali, R
    Pugeat, M
    Strauss, J
    Tan, S
    Taylor, A
    Wild, R
    Wild, S
    Ehrmann, D
    Lobo, R
    [J]. HUMAN REPRODUCTION, 2004, 19 (01) : 41 - 47
  • [6] Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice
    Le May, Cedric
    Chu, Khoi
    Hu, Min
    Ortega, Christina S.
    Simpson, Evan R.
    Korach, Kenneth S.
    Tsai, Ming-Jer
    Mauvais-Jarvis, Franck
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (24) : 9232 - 9237
  • [7] Correct homeostasis model assessment (HOMA) evaluation uses the computer program
    Levy, JC
    Matthews, DR
    Hermans, MP
    [J]. DIABETES CARE, 1998, 21 (12) : 2191 - 2192
  • [8] Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 diabetes
    Li, HY
    Lindholm, E
    Almgren, P
    Gustafsson, Å
    Forsblom, C
    Groop, L
    Tuomi, T
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) : 574 - 582
  • [9] Gender and neurogenin3 influence the pathogenesis of ketosis-prone diabetes
    Louet, J. -F.
    Smith, S. B.
    Gautier, J. -F.
    Molokhia, M.
    Virally, M. -L.
    Kevorkian, J. -P.
    Guillausseau, P. -J.
    Vexiau, P.
    Charpentier, G.
    German, M. S.
    Vaisse, C.
    Urbanek, M.
    Mauvais-Jarvis, F.
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 (10) : 912 - 920
  • [10] Ketosis-prone diabetes:: Dissection of a heterogeneous syndrome using an immunogenetic and β-cell functional classification, prospective analysis, and clinical outcomes
    Maldonado, M
    Hampe, CS
    Gaur, LK
    D'Amico, S
    Iyer, D
    Hammerle, LP
    Bolgiano, D
    Rodriguez, L
    Rajan, A
    Lernmark, Å
    Balasubramanyam, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) : 5090 - 5098